longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Seres Therap

MCRB

4.4802.61% ( -0.120 )
Trading: Sep 16, 11:16:48 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • STOCKS | Taikoo A Hits Record High As Seven Other Stocks See Unusual Moves

    CoinLive·Sep 9 at 01:36 AM
    MCRB-2.61%019720.00%
  • Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | MCRB Stock News

    StockTitan·Sep 8 at 02:00 PM
    MCRB-2.61%
  • Seres Therapeutics (NASDAQ:MCRB) Stock Price Crosses Above 50 Day Moving Average - Should You Sell?

    Market Beat·Sep 3 at 07:20 AM
    MCRB-2.61%GS-D+0.05%
  • Seres Therapeutics to present at H.C. Wainwright Global Investment Conference

    PUBT·Sep 1 at 11:02 AM
    MCRB-2.61%
  • Seres Therapeutics, Inc. 2Q 2026: Revenue $0.736M, Net income $4.581M, EPS $0.47— 10-Q Summary

    TradingView·Aug 5 at 02:41 PM
    MCRB-2.61%
  • Seres Therapeutics (MCRB) Receives a Buy from H.C. Wainwright

    Tip Ranks·Aug 5 at 02:36 PM
    MCRB-2.61%
  • Seres Q2 2026 Earnings: A $25 Million VOWST Gain Drives Quarterly Profit

    TradingKey·Aug 5 at 11:51 AM
    MCRB-2.61%
  • Seres Therapeutics holds annual shareholder meeting

    PUBT·Jul 8 at 08:08 PM
    MCRB-2.61%
  • Seres reports early data showing SER-155 eases ICI-related enterocolitis without systemic immunosuppressives in MSK trial

    PUBT·Jul 8 at 11:02 AM
    MCRB-2.61%